Toshihiro Maeda

Toshihiro Maeda currently serves as the Chief Operating Officer at Nxera Pharma, a position held since December 2023. Prior to this role, Toshihiro Maeda led various initiatives at Bristol Myers Squibb from July 2019 to December 2023, including serving as Cell Therapy Lead and Head of Commercial Excellence. At Merck, from October 2014 to June 2019, Toshihiro Maeda was the Chief of Staff for the Oncology Business Unit, as well as the New Product Lead for Global Diabetes Marketing and a Corporate Strategy Lead. Experience at McKinsey & Company spanned from September 2010 to September 2014 as an Associate, and earlier in the career, Toshihiro Maeda held the position of Associate Director at the Ministry of Economy, Trade and Industry from April 2002 to March 2009. Educational background includes an MBA in Business from The University of Chicago Booth School of Business, completed between 2008 and 2010.